Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure is a research paper published in Pharmaceutics (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: UM1 AI120176
NIH
Grant: R61/33 AI14-9665
NIH
Grant: U01 AI1448055
NIH
Grant: 68-3104 RRF_MU
NIH HHS
Grant: R61 AI149665
NIAID NIH HHS
Grant: U01 AI148055
National Institutes of Health
Grant: 5R33AI149665-04
NextGen Long-acting and targeted combination ART for Children with HIV
National Institutes of Health
Grant: 1UM1AI120176-01
Targeted Long-acting Combination Antiretroviral Therapy (TLC-ART)
Fields of Study
Keywords